These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The effectiveness of ciprofloxacin in bacterial skin infections]. Meisel C; Blenk H Z Hautkr; 1988 Dec; 63(12):1016-22. PubMed ID: 3218288 [TBL] [Abstract][Full Text] [Related]
8. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin. Parish LC; Jungkind DL Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880 [TBL] [Abstract][Full Text] [Related]
9. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime. Parish LC; Asper R Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041 [TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin: an update on clinical experience. Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063 [TBL] [Abstract][Full Text] [Related]
11. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections. Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040 [TBL] [Abstract][Full Text] [Related]
12. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial. Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections. Sanders WE Rev Infect Dis; 1988; 10(3):528-43. PubMed ID: 3293158 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with ciprofloxacin: analysis of a multicenter study. Karimi K Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309 [TBL] [Abstract][Full Text] [Related]
16. Bacterial infections of the lower urinary tract treated with ciprofloxacin or cefalexin--a comparative study. Polubiec A; Weuta H; Stepka K; Ktos K; Strazynska R; Jórasz J Infection; 1988; 16 Suppl 1():S62-4. PubMed ID: 3286518 [TBL] [Abstract][Full Text] [Related]
17. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure. Gentry LO; Koshdel A Am J Med; 1989 Nov; 87(5A):132S-135S. PubMed ID: 2686413 [TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study. Ramirez-Ronda C; Saavedra S Chemioterapia; 1987 Jun; 6(2 Suppl):432-4. PubMed ID: 3334591 [No Abstract] [Full Text] [Related]
19. Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections. Dominguez J; Palma F; Vega ME; Magaña JL; Ortiz G; Teresa-Hojyo M; Dominguez L Am J Med; 1989 Nov; 87(5A):136S-137S. PubMed ID: 2686414 [No Abstract] [Full Text] [Related]
20. A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial. Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Screen P; Becker N; August R J Clin Pharmacol; 1988 Feb; 28(2):179-89. PubMed ID: 3360968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]